The role of machine learning in cancer drug development
Drug Discovery World
SEPTEMBER 5, 2022
The success of targeted therapies in cancer comes on the heels of identifying specific molecular targets resulting from genetic variations. Modulations in protein expression levels or the presence of dysfunctional proteins observed in individuals with specific mutations act as biomarkers in selecting patients for targeted therapies. .
130 
Let's personalize your content